JP Morgan Maintains Overweight on UiPath, Lowers Price Target to $17
Portfolio Pulse from Benzinga Newsdesk
JP Morgan analyst Mark Murphy maintains an Overweight rating on UiPath (NYSE:PATH) but lowers the price target from $19 to $17.
October 23, 2024 | 5:39 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
JP Morgan's analyst Mark Murphy continues to rate UiPath as Overweight, indicating a positive outlook, but has reduced the price target from $19 to $17, suggesting a more cautious approach.
The Overweight rating suggests that JP Morgan still sees potential in UiPath, but the lowered price target indicates some concerns or adjustments in expectations. This mixed signal may lead to a neutral short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100